IV ketamine for Lantana — psychiatry-supervised, integrated with therapy.

RECO Health is an eighteen-minute drive from Old Town Lantana and Hypoluxo Island via Federal Highway, and it is the closest psychiatry-supervised IV ketamine and Spravato program north of Broward. Infusions are delivered in a monitored medical setting with continuous vitals and CADSS assessment, and every induction is paired with integration therapy — the design that gives ketamine's response its durability. Both IV ketamine and esketamine are offered on-site, so patients are not referred out mid-course when insurance coverage or dose flexibility becomes the deciding clinical factor.

Lantana and Hypoluxo Island occupy a quiet stretch of coastline between Delray Beach and West Palm — barrier-island neighborhoods where the closest psychiatry-supervised IV ketamine program sits eleven miles south, at RECO Health on Federal Highway. For residents of Old Town Lantana, Manalapan, and Ocean Ridge, the drive is roughly eighteen minutes. The treatment itself is a monitored medical procedure delivered inside an integrated psychiatric program, not a standalone wellness infusion.

Ketamine’s mechanism and why it works fast

Ketamine is a non-competitive NMDA receptor antagonist. Blocking that receptor produces a downstream cascade — increased AMPA receptor signaling, a rapid rise in brain-derived neurotrophic factor (BDNF), and measurable synaptogenesis in the prefrontal circuits implicated in depression. That mechanism is categorically different from what sertraline, escitalopram, or venlafaxine do. SSRIs and SNRIs modulate monoamine reuptake and require weeks of steady-state dosing before a clinical signal emerges on the PHQ-9.

Ketamine’s antidepressant and anti-suicidal effect, by contrast, emerges within hours to days. In the treatment-resistant depression pathway — patients who have failed two or more adequate antidepressant trials, often with augmentation attempts using lithium, aripiprazole, or quetiapine — that speed is the entire clinical argument for using it. In the acute suicidality pathway, it is frequently the difference between an inpatient admission and outpatient stabilization. Ketamine is not a first-line agent and RECO’s psychiatrists do not present it as one; it belongs at the point in the sequence where waiting six weeks for a monoamine response is no longer clinically defensible.

The same NMDA antagonism explains ketamine’s utility in refractory PTSD, particularly where hyperarousal and intrusive re-experiencing have not remitted with sertraline, prazosin, or a full course of EMDR or prolonged exposure.

The 40-minute infusion, monitored recovery, and six-session induction

Each infusion session runs approximately two hours end-to-end. Intake takes twenty minutes: baseline vital signs, a brief CADSS (Clinician-Administered Dissociative States Scale) reading, a PHQ-9 and a Columbia Suicide Severity Rating Scale before every session, and a review of medication changes since the last visit. The infusion itself is 0.5 mg/kg of racemic ketamine over forty minutes, weight-adjusted and occasionally titrated up to 0.75 mg/kg for patients who did not achieve response at the standard dose.

Blood pressure, heart rate, respiratory rate, and oxygen saturation are tracked continuously by nursing staff. Dissociative symptoms peak around minute twenty and taper before the drip ends. Post-infusion recovery is another thirty to sixty minutes in a low-stimulation room until the CADSS returns near baseline and vitals are stable. Clients cannot drive; a family member, spouse, or rideshare is required.

The standard induction is six infusions across two to three weeks — the interval where sustained response either consolidates or does not. Non-responders after the fourth infusion are re-evaluated. Responders move to a maintenance schedule dictated by the duration of their individual response, typically a single booster every three to six weeks.

Integration with psychotherapy makes response durable

Ketamine opens a window; therapy determines whether the client walks through it. The neuroplastic state produced by the infusion — the elevated BDNF, the transiently more malleable prefrontal circuitry — is the substrate that lets cognitive and emotional shifts consolidate. Without deliberate work in that window, response duration is shorter and relapse is more common. The published literature on ketamine-assisted psychotherapy is consistent on that point.

RECO’s ketamine therapy protocol pairs each infusion series with integration sessions, typically scheduled the day after each of the six infusions. The therapy modality is matched to the presentation. Depression with rumination is often approached with cognitive behavioral therapy (CBT) or acceptance and commitment therapy (ACT). Trauma material that surfaces during infusions is worked with EMDR or a prolonged-exposure framework. Personality-organized emotional dysregulation is met with DBT skills. Motivational interviewing (MI) threads through all of it when substance use is a comorbid concern.

Integration is not optional at RECO — it is how the treatment is designed to work, and it is why our psychiatry team declines to run infusion-only care.

Ketamine vs Spravato and how we decide

IV racemic ketamine and intranasal esketamine (Spravato) are related, not interchangeable. Spravato is FDA-approved for treatment-resistant depression and for depressive symptoms in adults with acute suicidal ideation. Because it is FDA-approved, most commercial insurance carriers cover it under the manufacturer’s REMS protocol, which mandates two-hour on-site monitoring at a certified center. IV ketamine, in contrast, is off-label; nearly all IV ketamine in the United States is cash-pay.

The clinical differences matter as much as the financial ones. Spravato’s induction is twice-weekly for four weeks, then weekly, then every one to two weeks — a longer schedule with less dose flexibility. IV ketamine allows precise weight-based titration, a compressed six-session induction, and, in some patients, a qualitatively cleaner clinical response.

The decision is made during the psychiatry consult, not in a marketing brochure. If insurance coverage is the deciding factor and the patient can commit to the Spravato schedule, we start there. If dose flexibility, response quality at prior dosing, or a compressed timeline matters more, IV ketamine is the appropriate choice. RECO offers both, and switching between them mid-course is clinically ordinary when the first choice does not deliver.

What to expect at the first visit from Lantana

The first appointment is a psychiatric evaluation, not an infusion. A RECO psychiatrist takes a full history — prior antidepressant trials with adequate dose and duration, augmentation attempts, prior response to bupropion or mirtazapine, any history of psychosis, bipolar spectrum illness, uncontrolled hypertension, or active substance use disorder. PHQ-9, GAD-7, and Columbia scales are administered. Bloodwork and an ECG are ordered if not on file within the last twelve months.

If ketamine is indicated, induction is scheduled to begin within one to two weeks. Patients on benzodiazepines are counseled that same-day dosing blunts ketamine’s antidepressant effect; a taper or session-day hold is discussed. Patients from Old Town Lantana or Hypoluxo Island typically leave the consult with an infusion calendar and a designated driver plan already in place.

Insurance and admissions from Lantana

Spravato is covered by Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS at RECO Health under the standard REMS-compliant workflow. Prior authorization is handled by our admissions team; patients receive a written estimate of any coinsurance before the first dose. IV ketamine is cash-pay and priced per infusion, with induction and maintenance packages available; single-case agreements are occasionally negotiable when Spravato has failed and clinical justification is strong.

Admissions from Lantana typically move from a first phone call to a scheduled psychiatric consult within two to five business days. The drive from Old Town Lantana or Manalapan to RECO’s Delray Beach campus runs eighteen minutes via Federal Highway, less on A1A outside of season. Program hours accommodate patients continuing to work; most infusions are scheduled mid-morning to allow same-day recovery before returning home.

Serving residents of: Hypoluxo Island, Manalapan, Ocean Ridge, Old Town Lantana.